By Carol Davis For The Mail On Sunday
Published: 22:01 GMT, 2 November 2019 | Updated: 22:01 GMT, 2 November 2019
A spray that heals the dangerous wounds that blight patients with diabetes could save thousands from amputation.
The new treatment delivers vital oxygen to painful foot sores and ulcers which can fester for months or even years – and appears to accelerate the recovery process.
Patients with diabetes are at an increased risk of developing chronic wounds – skin injuries that do not heal within the amount of time expected.
The new treatment delivers vital oxygen to painful foot sores and ulcers which can fester for months or even years – and appears to accelerate the recovery process
In fact, every year 169,000 UK patients with type 1 and type 2 diabetes develop a foot ulcer – an open, angry sore, usually on the base of the foot, which can form from the tiniest of cuts.
These can become infected and cause irreversible damage to surrounding tissue, leaving patients with no choice but to have their toes or foot surgically removed.
Official figures show that more than 26,000 lower-limb amputations were carried out in England as a result of complications stemming from diabetes between 2014 and 2016. And podiatrist Jacob Penkethman, from Hull University Hospitals NHS Trust, says: ‘Amputations are by no means the end of the story – there is a high risk of death within five years.
‘This can be from infection or from the strain on other internal organs or from lack of mobility.’
The new Granulox spray, which is available on the NHS, has been shown to halve the time it takes foot ulcers to heal, and may reduce the risk of amputation.
‘I tried Granulox on